SavedAdd your journal

Journals / Glokom Katarakt / 2021 / Cilt: 16 - Sayı: 2

Adherence to Drop Treatment in Glaucoma Patients and Its Relationship with Progression

Serek TEKİN
Muhammet Derda ÖZER
Tekin YAŞAR
Muhammed BATUR
Erbil SEVEN
Halit ÖCAL
Pages
83–88
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was found that 66% of the patients adhered to eye drop treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the adherence of glaucoma patients to eye drop therapy and determine the effects of treatment adherence on disease progression.
📊
Key Findings & Data:Materials and Methods: A total of 147 patients followed at Van Yüzüncü Yıl University Department of Ophthalmology, between March 2019 and June 2019 were included in the study.
💡
Conclusion & Impact:Results: It was found that 66% of the patients adhered to eye drop treatment.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the adherence of glaucoma patients to eye drop therapy and determine the effects of treatment adherence on disease progression. Materials and Methods: A total of 147 patients followed at Van Yüzüncü Yıl University Department of Ophthalmology, between March 2019 and June 2019 were included in the study. Patients were examined and asked questions. Patients underwent peripapillary retinal nerve fi ber layer analysis via optical coherence tomography. Results: It was found that 66% of the patients adhered to eye drop treatment. The most common reasons for non-adherence were forgetting (40%) and running out of eye drop (38%). Correct instillation technique was demonstrated by 59% of the patients. There was signifi cantly less disease progression in adherent patients compared to non-adherent patients (p=0.002) and in patients with correct instillation technique compared to those without (p=0.001). Conclusion: This study showed adherence to eye drop therapy was 66% among glaucoma patients and 59% of patients showed correct drop instillation technique. More progression was observed in patients with poor adherence and patients who did not instill drops correctly.

🔖

Cite This Article

TEKİN, S., ÖZER, M. D., YAŞAR, T., BATUR, M., SEVEN, E., ÖCAL, H. (2022). Adherence to Drop Treatment in Glaucoma Patients and Its Relationship with Progression. Glokom Katarakt, Cilt: 16 - Sayı: 2, 83–88. https://ajindex.com/articles/525758

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Leskea MC, Heijl A, Hyman L, et al. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol 2004; 15: 102-6
  2. Leske MC, Heijl A, Hyman L, et al. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999; 106: 2144-53
  3. Anderson DR. Collaborative normal tension glaucoma study. Current Opin Ophthalmol 2003; 14: 86-90
  4. Lee DA, Higginbotham EJ. Glaucoma and its treatment: a review. Am J Health-Syst Ph 2005; 62: 691-9
  5. Osman EA, Alqarni BA, AlHasani SS, et al. Compliance of Glaucoma Patients to Ocular Hypotensive Medications Among the Saudi Population. J Ocul Pharmacol Ther 2016; 32: 50-4
  6. Masoud M, Sharabi-Nov A, Pikkel J. Noncompliance with Ocular Hypertensive Treatment in Patients with Primary Open Angle Glaucoma among the Arab Population in Israel: A Cross- Sectional Descriptive Study. J Ophthalmol 2013; 2013: 405130
  7. Olthoff CM, Schouten JS, van de Borne BW, et al. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmol 2005; 112: 953-61
  8. Deokule S, Sadiq S, Shah S. Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthal Physl Opt 2004; 24: 9-15
  9. Gupta R, Patil B, Shah BM, et al. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma 2012; 21: 189-92
  10. Gatwood JD, Johnson J, Jerkins B. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study. J Glaucoma 2017; 26: 1056-61
  11. McVeigh KA, Vakros G. The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clin Ophthalmol 2015; 9: 813
  12. Kholdebarin R, Campbell RJ, Jin Y-P, et al. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol 2008; 43: 454-61
  13. Leung CK-s, Cheung CYL, Weinreb RN, et al. Evaluation of retinal nerve fi ber layer progression in glaucoma: a study on optical coherence tomography guided progression analysis. Invest Ophthalmol Vis Sci 2010; 51: 217-22
  14. Tatham AJ, Medeiros FA. Detecting structural progression in glaucoma with optical coherence tomography. Ophthalmol 2017; 124: S57-S65
  15. Medeiros FA, Zangwill LM, Alencar LM, et al. Detection of glaucoma progression with stratus OCT retinal nerve fi ber layer, optic nerve head, and macular thickness m